Literature DB >> 30415300

Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting.

Andreea Farcas1, Noemi Beatrix Bulik1, Andreea Popa1, Agatha Mensah Achampong1, Camelia Bucsa2, Cristina Mogosan1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30415300     DOI： 10.1007/s00228-018-2596-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

2.  Characterization of adverse drug reactions causing admission to an intensive care unit.

Authors:  Camilo Rojas-Velandia; Jair Ruiz-Garzón; Juan-Carlos Moscoso-Alcina; Álvaro Vallejos-Narvaéz; Jenny Castro-Canoa; Yuri Bustos-Martínez; Max Flórez-Cutiva; Mabel Contreras-Muñoz; Jully-Carolina Gómez-Gil; Carlos-Alberto Calderón-Ospina
Journal:  Br J Clin Pharmacol       Date:  2017-01-10       Impact factor: 4.335

3.  Toward the operational identification of adverse drug reactions.

Authors:  F E Karch; L Lasagna
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

4.  The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients.

Authors:  Carlos Calderón-Ospina; Carlos Bustamante-Rojas
Journal:  Int J Pharm Pract       Date:  2010-08

5.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.